Sopharma AD
Pharmaceutical producer of Rx, OTC, and plant-based medicines for international markets.
SFA | BSOBGN
Overview
Corporate Details
- ISIN(s):
- BG11SOSOBT18
- LEI:
- 097900BGGW0000048796
- Country:
- Bulgaria
- Address:
- ул. Лъчезар Станчев 5, кула А, ет.18, 1756 София
- Website:
- https://www.sopharmagroup.com/
- Sector:
- Manufacturing
Description
Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-12-08 17:08 |
Notification for buy-back treasury shares
|
English | 46.5 KB | ||
| 2023-12-07 16:36 |
zal01_SFA_buyback_08122023_espi.pdf
|
English | 72.7 KB | ||
| 2023-12-05 14:48 |
Notification from Simeon Donev under Art. 19 of Regulation (EU) ą 596/2014 of t…
|
English | 142.1 KB | ||
| 2023-12-05 14:41 |
Notification from Simeon Donev under Art. 19 of Regulation (EU) ą 596/2014 of t…
|
English | 140.6 KB | ||
| 2023-12-05 14:26 |
Notification from "Sofprint Group" AD under Art. 19 of Regulation (EU) No 596/2…
|
English | 139.9 KB | ||
| 2023-12-05 14:19 |
Notification from "Donev investments holding" AD under Art. 19 of Regulation (E…
|
English | 153.5 KB | ||
| 2023-12-05 14:15 |
Notification from "Donev investments holding" AD under Art. 19 of Regulation (E…
|
English | 158.8 KB | ||
| 2023-12-05 14:06 |
Notification from Ognian Donev under Art. 19 of Regulation (EU) ą 596/2014 of t…
|
English | 142.2 KB | ||
| 2023-12-04 15:58 |
Notification from "Donev investments holding" AD under Art. 19 of Regulation (E…
|
English | 153.1 KB | ||
| 2023-12-04 15:46 |
Notification from Ognian Donev under Art. 19 of Regulation (EU) ą 596/2014 of t…
|
English | 142.7 KB | ||
| 2023-12-04 14:02 |
Treasury shares
|
English | 64.8 KB | ||
| 2023-11-29 13:41 |
Consolidated financial report as at 30 September 2023
|
Polish | 2.7 MB | ||
| 2023-11-24 16:01 |
Minutes of the Extraordinary General Meeting of Shareholders of Sopharma AD, he…
|
Polish | 465.0 KB | ||
| 2023-11-24 11:31 |
Notification on the terms and conditions for distribution of the dividend
|
English | 63.2 KB | ||
| 2023-11-20 13:01 |
Sales revenues for October 2023
|
English | 57.7 KB |
Automate Your Workflow. Get a real-time feed of all Sopharma AD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sopharma AD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sopharma AD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
